HealthcareBayer bets $547M on therapies for RNA-driven cancersBy Helitra.com·August 30, 2024·1 min read Bayer bets $547M on therapies for RNA-driven cancers Source: SeekingalphaADVERTISEMENT ADVERTISEMENT547M Bayer bets cancers RNAdriven therapies Post navigation Previous storyGain slips after early-stage data for Parkinson’s therapyNext storydentalcorp Holdings to make normal course issuer bid
Fitness · HealthcareEveryone In Hollywood Is Microdosing This Medication for Clearer SkinNovember 17, 2026When you buy through links on our articles, Future and its syndication partners may earn a commission. Although the maximalism trend is alive…
Fitness · HealthcareTired of Basic Pushups? This Dynamic Yoga-Inspired Sweep Hits Chest, Shoulders, and LatsNovember 17, 2026How many years have you been doing good old-fashioned pushups? Probably even longer than you can remember. Pushups are a classic for their…
Fitness · HealthcareThe ‘Godzilla’ of Weight Loss Drugs Could Take ‘Ozempic Face’ to the ExtremeNovember 17, 2026From sunken under-eyes to hollow temples and loose skin, many people using weight-loss drugs report dramatic side effects on their appearance. Now, experts…